SomnoMed Limited (SOMNF PINK) stock market data APIs
$0.17
0(0%)
as of January 14, 2025
SomnoMed Limited Financial Data Overview
Price chart is built with
Anychart
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Prev. Close
0.17
Open
0.17
Volume
0
High
0.17
Low
0.17
52 wk Range
0.13-0.39
Market Cap
58 487 K
Shares Outstanding
216 M
Revenue
91 651 K
EPS
-0.008
Beta
1.382
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SomnoMed Limited data using free add-ons & libraries
Get SomnoMed Limited Fundamental Data
SomnoMed Limited Fundamental data includes:
- Net Revenue: 91 651 K
- EBITDA: -6 487 805
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SomnoMed Limited News
New
Revenues Working Against SomnoMed Limited's (ASX:SOM) Share Price
SomnoMed Limited's (ASX:SOM) price-to-sales (or "P/S") ratio of 1x might make it look like a strong buy right now compared to the Medical Equipment industry in Australia, where around half of the comp...
The past five years for SomnoMed (ASX:SOM) investors has not been profitable
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. For example the SomnoMed Limited (ASX:SOM) share price dropped 60% over five ye...
Shareholders May Not Be So Generous With SomnoMed Limited's (ASX:SOM) CEO Compensation And Here's Why
In the past three years, the share price of SomnoMed Limited (ASX:SOM) has struggled to grow and now shareholders are sitting on a loss. In addition, the company's per-share earnings growth is not loo...
A SomnoMed Limited (ASX:SOM) insider increased their holdings by 167% last year
Looking at SomnoMed Limited's (ASX:SOM ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there w...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
